Sertraline vs. Vitamin d: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Sertraline and Vitamin d. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 608,067 people who take Sertraline and Vitamin d, and is updated regularly.
What is Sertraline?
Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 153,305 Sertraline users. Check the latest studies of Sertraline.
What is Vitamin d?
Vitamin d has active ingredients of ergocalciferol. It is often used in low vitamin d. eHealthMe is studying from 294,095 Vitamin d users. Check the latest studies of Vitamin d.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
608,067 people who take Sertraline and Vitamin d are studied.

Drugs being compared in this study:
- Sertraline (sertraline hydrochloride)
- Vitamin D (ergocalciferol)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Sertraline:
- not at all: 3.56 %
- somewhat: 19.6 %
- moderate: 35.99 %
- high: 30.3 %
- very high: 10.55 %
Vitamin D:
- not at all: 4.25 %
- somewhat: 20.92 %
- moderate: 35.05 %
- high: 29.82 %
- very high: 9.96 %
Want to compare Sertraline with Vitamin d?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Sertraline (146,484 reports)
- Vitamin d (282,728 reports)
Browse all side effects of Sertraline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vitamin d:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on sertraline hydrochloride and ergocalciferol (the active ingredients of Sertraline and Vitamin d, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pain and Tachycardia Aggravated - 5 seconds ago
- Could Aspirin cause Onychoclasis? - 31 seconds ago
- Sertraline and Myocardial Infarction for Men aged 30-39 - 44 seconds ago
- Sertraline and Mi for Men aged 30-39 - 44 seconds ago
- Sertraline and Acute Mi for Men aged 30-39 - 44 seconds ago
- Sertraline and Heart Attack for Men aged 30-39 - 45 seconds ago
- Kava vs. Risperdal, side effect and effectiveness comparison - 48 seconds ago
- Could Celebrex cause Staphylococcal Infection? - 57 seconds ago
- Drug interactions of Levoxyl and Prilosec - a minute ago
- Zoloft vs. Reglan, side effect and effectiveness comparison - a minute ago